Home
About
FAQ
History (27)
Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
Microbiome-immune-metabolic axis in the epidemic of childhood obesity: Evidence and opportunities.
The cocaine and oxycodone biobanks, two repositories from genetically diverse and behaviorally characterized rats for the study of addiction.
Osteochondritis dissecans of the tarsal navicular bone: imaging findings in four patients.
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
Okwundu N, Cline A, Feldman SR. Difference in vasoconstrictors: oxymetazoline vs. brimonidine. J Dermatolog Treat. 2021 Mar; 32(2):137-143.
View in:
PubMed
subject areas
Administration, Topical
Clinical Trials as Topic
Dermatitis
Erythema
Humans
Oxymetazoline
Rosacea
Treatment Outcome
Vasoconstrictor Agents
authors with profiles
Steven R. Feldman MD, PhD